| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr6:27256800-27258400 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 2 |
chr6:27256800-27258600 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 3 |
chr6:27257800-27258800 |
Bivalent/Poised TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 4 |
chr6:27257800-27259000 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
| 5 |
chr6:27257800-27259000 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
| 6 |
chr6:27257800-27259000 |
Active TSS |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 7 |
chr6:27257800-27259200 |
Bivalent/Poised TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
| 8 |
chr6:27257800-27259200 |
Bivalent/Poised TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
| 9 |
chr6:27257800-27259200 |
Active TSS |
NHEK |
skin
|
| 10 |
chr6:27257800-27259400 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
| 11 |
chr6:27257800-27259400 |
Bivalent/Poised TSS |
H1 Cell Line |
embryonic stem cell
|
| 12 |
chr6:27257800-27259400 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
| 13 |
chr6:27257800-27259600 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
| 14 |
chr6:27257800-27260000 |
Active TSS |
H9 Cell Line |
embryonic stem cell
|
| 15 |
chr6:27258000-27258600 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
| 16 |
chr6:27258000-27258600 |
Active TSS |
K562 |
blood
|
| 17 |
chr6:27258000-27259000 |
Active TSS |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
| 18 |
chr6:27258000-27259000 |
Bivalent/Poised TSS |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 19 |
chr6:27258000-27259200 |
Bivalent/Poised TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 20 |
chr6:27258000-27259600 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
| 21 |
chr6:27258000-27260000 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
| 22 |
chr6:27258000-27261800 |
ZNF genes & repeats |
Pancreatic Islets |
Pancreatic Islet
|
| 23 |
chr6:27258200-27258400 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 24 |
chr6:27258200-27258400 |
Enhancers |
HMEC |
breast
|
| 25 |
chr6:27258200-27258600 |
Flanking Bivalent TSS/Enh |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
| 26 |
chr6:27258200-27258600 |
Active TSS |
A549 |
lung
|
| 27 |
chr6:27258200-27258600 |
Bivalent Enhancer |
NH-A |
brain
|
| 28 |
chr6:27258200-27259200 |
Bivalent/Poised TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
| 29 |
chr6:27258200-27259200 |
Active TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 30 |
chr6:27258200-27259200 |
Bivalent/Poised TSS |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
| 31 |
chr6:27258200-27259200 |
Bivalent/Poised TSS |
Osteobl |
bone
|
